These include other steroidogenesis inhibitors (eg, ketoconazole, levoketoconazole, metyrapone), somatostatin receptor ligands (pasireotide), dopamine receptor agonists (cabergoline), and glucocorticoid receptor blockers (mifepristone, when hyperglycemia is also present) [9]. Here, NR3C1 is linked to Hyperglycemia.